Colorado
Prescription drug spending and prescribing in Colorado, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $3.7B for prescriptions written in Colorado, the 27th most of 52 states and territories, and 4.7% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $3.7B
- Medicaid drugs, 2025: $1.6B
- Opioid share of claims: 4.7%
- Life-science raises, 2 years: $454M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Colorado | United States | Difference |
|---|---|---|---|
| Opioids | 4.7% | 3.5% | +32% |
| Antibiotics | 4.5% | 4.4% | +2% |
| Antipsychotics | 1.7% | 1.7% | +0% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Colorado's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Dabigatran Etexilate Mesylate | 4.0× | 37,403 |
| Diph,pertuss(Acell),tet Vac/Pf | 4.0× | 12,690 |
| Ciclesonide | 3.8× | 9,923 |
| Buprenorphine | 2.8× | 17,400 |
| Insulin Glargine-Yfgn | 2.8× | 19,564 |
| Progesterone, Micronized | 2.6× | 20,123 |
| Hydromorphone Hcl | 2.5× | 23,702 |
| Polymyxin B Sulf/Trimethoprim | 2.2× | 11,132 |
| Tiotropium Bromide | 2.2× | 53,678 |
| Oxycodone Hcl | 2.2× | 249,557 |
Biggest Medicaid Drugs
What Colorado's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
70 Form D raises by companies based in Colorado in the last two years; the 10 largest. See all raises- CoRegen, Inc.$63M · Biotech · May 22, 2025
- Mustang SNF Holdings LLC$40M · Other health care · Sep 24, 2025
- OrthoBio Therapeutics, Inc.$31M · Biotech · Jul 2, 2025
- VitriVax, Inc.$29M · Biotech · Nov 17, 2025
- Integrated Care Partners, Inc.$28M · Other health care · May 12, 2025
- Stillwater Topco, LLC$25M · Other health care · Mar 9, 2026
- TriSalus Life Sciences, Inc.$22M · Biotech · May 8, 2025
- CoRegen, Inc.$21M · Biotech · Feb 28, 2025
- Posterity Health, Inc.$17M · Other health care · Jan 24, 2025
- Soar Health Inc.$17M · Other health care · Dec 2, 2025
State Attorney General Health-Care Cases
Antitrust cases Colorado joined, newest first; see every case- Plaintiff States and FTC v. CVET TOPCO, L.P. et al.2026 · Pending
- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Colorado ex rel. Weiser v. Unitedhealth Group;2020 · Settled
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
- State of Colorado et al v. Warner Chilcott, 1:05-cv-02182 (D.D.C.2005)2005 · Settled
- Maryland et al. v. Perrigo Company, No. 1:04CV01398 (D.D.C. Aug. 17, 2004)2004 · Settled
- Texas et al. v. Organon (Remeron), No. 04-5126 (D.N.J. 2004)2004 · Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG